{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T14:22:39Z","timestamp":1775744559729,"version":"3.50.1"},"reference-count":40,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T00:00:00Z","timestamp":1613174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010621","name":"Uniwersytet Medyczny w Lublinie","doi-asserted-by":"publisher","award":["DS164"],"award-info":[{"award-number":["DS164"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Psoriasis (Ps) is an immune-mediated inflammatory skin disease that is widely associated with the clinical features of metabolic syndrome (MetS), including hypertension, abdominal obesity, insulin resistance, type 2 diabetes and dyslipidemia. Osteopontin (OPN), a multifunctional protein involved in the modulation of inflammatory processes, may contribute to the development of atherosclerosis and MetS. Therefore, the aim of the study was the assessment of the correlation between OPN concentration in the peripheral blood and the presence of MetS as well as its particular components in the Ps patients. The study comprised 107 male Ps patients (50 patients with MetS and 57 without MetS) and 38 healthy volunteers (HVs). The concentration of OPN in serum was determined using enzyme-linked immunosorbent assay (ELISA) method. Fasting blood glucose and lipid profile components: total cholesterol (total CHOL), high-density lipoprotein cholesterol (HDL-CHOL), low-density lipoprotein cholesterol (LDL-CHOL), triglycerides (TG) were examined. Ps patients with MetS had significantly higher obesity, systolic blood pressure, TG, CHOL\/HDL, LDL\/HDL and TG\/HDL ratios than Ps patients without MetS. OPN serum concentration was significantly higher in the Ps patients than in the HVs (p = 0.022) but not significantly different between the Ps patients with and without MetS (p = 0.275). OPN serum concentration in Ps patients correlated negatively with total CHOL (p = 0.004) and TG (p = 0.009). OPN is increased in Ps patients and may serve as a biomarker of some lipid abnormalities in them.<\/jats:p>","DOI":"10.3390\/jcm10040755","type":"journal-article","created":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T02:08:12Z","timestamp":1613268492000},"page":"755","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Osteopontin Serum Concentration and Metabolic Syndrome in Male Psoriatic Patients"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4106-3051","authenticated-orcid":false,"given":"Joanna","family":"Bartosi\u0144ska","sequence":"first","affiliation":[{"name":"Department of Cosmetology and Aestetic Medicine, Medical University of Lublin, ul. Chod\u017aki 1, 20-093 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9073-876X","authenticated-orcid":false,"given":"Joanna","family":"Przepi\u00f3rka-Kosi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, ul. Staszica 11, 20-081 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0002-8591","authenticated-orcid":false,"given":"Beata","family":"Sarecka-Hujar","sequence":"additional","affiliation":[{"name":"Department of Basic Biomedical Science, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, ul. Kasztanowa 3, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3517-6711","authenticated-orcid":false,"given":"Dorota","family":"Raczkiewicz","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, School of Public Health, Center of Postgraduate Medical Education, ul. Kleczewska 61\/63, 01-826 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Kowal","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, ul. Staszica 11, 20-081 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Chyl-Surdacka","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, ul. Staszica 11, 20-081 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaros\u0142aw","family":"Bartosi\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Therapy, Independent Public Clinical Hospital No. 4 in Lublin, ul. Jaczewskiego 8, 20-954 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1700-0317","authenticated-orcid":false,"given":"Jakub","family":"Kosi\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation and Orthopedics, Medical University of Lublin, ul. Jaczewskiego 8, 20-954 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3176-9870","authenticated-orcid":false,"given":"Dorota","family":"Krasowska","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, ul. Staszica 11, 20-081 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gra\u017cyna","family":"Chodorowska","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, ul. Staszica 11, 20-081 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fphar.2020.00117","article-title":"Pathogenesis of Chronic Plaque Psoriasis and Its Intersection with Cardio-Metabolic Comorbidities","volume":"11","author":"Gisondi","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/jdv.16273","article-title":"The role of the interleukin-23\/Th17 pathway in cardiometabolic comorbidity associated with psoriasis","volume":"34","author":"Egeberg","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2169\/internalmedicine.56.8209","article-title":"Cardiovascular and Metabolic Diseases Comorbid with Psoriasis: Beyond the Skin","volume":"56","author":"Furue","year":"2017","journal-title":"Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/1744666X.2016.1213631","article-title":"Co-morbidity in psoriasis: Mechanisms and implications for treatment","volume":"13","author":"Skov","year":"2017","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/ijd.13420","article-title":"Interleukin-17 as a factor linking the pathogenesis of psoriasis with metabolic disorders","volume":"56","author":"Placek","year":"2017","journal-title":"Int. J. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jaad.2017.06.028","article-title":"The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events","volume":"77","author":"Egeberg","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e000062","DOI":"10.1161\/JAHA.113.000062","article-title":"Psoriasis and major adverse cardiovascular events: A systematic review and meta-analysis of observational studies","volume":"2","author":"Armstrong","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Kothari, A.N., Arffa, M.L., Chang, V., Blackwell, R.H., Syn, W.K., Zhang, J., Mi, Z., and Kuo, P.C. (2016). Osteopontin\u2014A Master Regulator of Epithelial-Mesenchymal Transition. J. Clin. Med., 5.","DOI":"10.3390\/jcm5040039"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/7675437","article-title":"Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases","volume":"13","author":"Clemente","year":"2016","journal-title":"J. Immunol. Res."},{"key":"ref_10","first-page":"55","article-title":"Osteopontin: A multifunctional molecule","volume":"1","author":"Acar","year":"2010","journal-title":"J. Med. Med. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/ATVBAHA.107.144824","article-title":"Osteopontin: A multifunctional molecule regulating chronic inflammation and vascular disease","volume":"27","author":"Scatena","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_12","first-page":"ZE10","article-title":"OPN \u2013Revisited","volume":"9","author":"Subramani","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.atherosclerosis.2014.07.004","article-title":"Osteopontin\u2014A multi-modal marker and mediator in atherosclerotic vascular disease","volume":"236","author":"Wolak","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11883-009-0032-8","article-title":"Osteopontin: A multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification","volume":"11","author":"Cho","year":"2009","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/154405910608500503","article-title":"Osteopontin and mucosal protection","volume":"85","author":"Sodek","year":"2006","journal-title":"J. Dent. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bbrc.2016.01.142","article-title":"Pathophysiological role of osteopontin and angiotensin II in atherosclerosis","volume":"471","author":"Ding","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.molmet.2014.03.004","article-title":"Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes","volume":"3","author":"Kahles","year":"2014","journal-title":"Mol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/aps.2015.37","article-title":"Wogonin suppresses osteopontin expression in adipocytes by activating PPAR\u03b1","volume":"36","author":"Zhang","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1249\/MSS.0b013e31828093c1","article-title":"Alterations in osteopontin modify muscle size in females in both humans and mice","volume":"45","author":"Hoffman","year":"2013","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3346\/jkms.2013.28.10.1496","article-title":"High serum osteopontin levels are associated with low bone mineral density in postmenopausal women","volume":"28","author":"Cho","year":"2013","journal-title":"J. Korean Med. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2310\/JIM.0b013e3182761264","article-title":"The value of osteopontin in the assessment of bone mineral density status in postmenopausal women","volume":"61","author":"Fodor","year":"2013","journal-title":"J. Investig. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3109\/10641961003628494","article-title":"The relationship between osteopontin and adiponectin in patients with essential hypertension","volume":"32","author":"Kurata","year":"2010","journal-title":"Clin. Exp. Hypertens."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1475-2840-9-70","article-title":"Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus","volume":"9","author":"Yan","year":"2010","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00403-013-1392-z","article-title":"Osteopontin and adiponectin: How far are they related in the complexity of psoriasis?","volume":"305","author":"Kadry","year":"2013","journal-title":"Arch. Dermatol. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/ced.12657","article-title":"Assessment of serum levels of osteopontin, selenium and prolactin in patients with psoriasis compared with healthy controls, and their association with psoriasis severity","volume":"40","author":"Toossi","year":"2015","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cyto.2015.04.015","article-title":"Osteopontin, CCL5 and CXCL9 are independently associated with psoriasis, regardless of the presence of obesity","volume":"74","author":"Duarte","year":"2015","journal-title":"Cytokine"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cyto.2011.03.020","article-title":"Systemic blood osteopontin, endostatin, and E-selectin concentrations after vertical banding surgery in severely obese adults","volume":"55","author":"Komorowski","year":"2011","journal-title":"Cytokine"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ahmad, R., Al-Mass, A., Al-Ghawas, D., Shareif, N., Zghoul, N., Melhem, M., Hasan, A., Al-Ghimlas, F., Dermime, S., and Behbehani, K. (2013). Interaction of osteopontin with IL-18 in obese individuals: Implications for insulin resistance. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0063944"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1600-0625.2009.00926.x","article-title":"Osteopontin and the skin: Multiple emerging roles in cutaneous biology and pathology","volume":"18","author":"Buback","year":"2009","journal-title":"Exp. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1210\/jc.2007-0349","article-title":"Plasma osteopontin levels and expression in adipose tissue are increased in obesity","volume":"92","author":"Colina","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/ijd.13167","article-title":"Serum osteopontin level and common carotid artery intima-media wall thickness in psoriasis","volume":"55","author":"Robati","year":"2016","journal-title":"Int. J. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbrc.2015.11.079","article-title":"Epigenetic regulation of glucose-stimulated osteopontin (OPN) expression in diabetic kidney","volume":"469","author":"Cai","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jaad.2008.09.046","article-title":"Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis","volume":"60","author":"Chen","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/HYPERTENSIONAHA.107.102640","article-title":"Osteopontin in rat renal fibroblasts: Functional properties and transcriptional regulation by aldosterone","volume":"51","author":"Irita","year":"2008","journal-title":"Hypertension"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1530\/EJE-15-0791","article-title":"Increased circulating osteopontin levels in adult patients with type 1 diabetes mellitus and association with dysmetabolic profile","volume":"174","author":"Barchetta","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/01.ATV.0000229701.42828.73","article-title":"Effect of atorvastation on plasma osteopontin levels in patients with hypercholesterolemia","volume":"26","author":"Tanaka","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/exd.13467","article-title":"Interleukin-17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities","volume":"27","author":"Krueger","year":"2018","journal-title":"Exp. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1468-3083.2011.04010.x","article-title":"Plasma and tissue osteopontin in relation to plasma selenium in patients with psoriasis","volume":"26","author":"Kadry","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jdermsci.2014.04.013","article-title":"Expression of osteopontin genotypes (T-4754-C and A-9138-C) in psoriasis and their relation to metabolic syndrome","volume":"75","author":"Hegazy","year":"2014","journal-title":"J. Dermatol. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s40618-014-0174-6","article-title":"The interplay among iron metabolism, endothelium and inflammatory cascade in dysmetabolic disorders","volume":"38","author":"Yegin","year":"2015","journal-title":"J. Endocrinol. Invest."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/4\/755\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:23:48Z","timestamp":1760160228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/4\/755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,13]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["jcm10040755"],"URL":"https:\/\/doi.org\/10.3390\/jcm10040755","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,13]]}}}